Established in 1997, Macrogen is a global digital healthcare company committed to enhancing the well-being of humanity through a healthcare platform and personal genome sequencing services. With the goal of providing every individual with a $100 "Genetic Blueprint" for a long and healthy life, Macrogen offers comprehensive genomic solutions that include DNA/RNA sequencing, personal genetic testing, microbiome analysis, single-cell sequencing, proteomics, cancer gene panels for clinical diagnosis, and even animal genetic testing. We have served over 18,000 clients across 153 countries, adapting to the era of personalized medicine by focusing on disease prediction, prevention, tailored drug therapies, and new-drug development.